When words fall short, care shows through quiet understanding and compassion. It’s more than just completing tasks. This was the reality for a devoted husband as he watched his nonverbal wife struggle to express her needs. Determined to ensure she received the best care, he turned to Southern California Caregiving. What followed was a team of compassionate caregivers who intuitively understood her unspoken needs. The impact was profound—she remained safe and never experienced a fall or hospitalization. Her family saw the difference and felt reassured. She radiated peace, and her calm demeanor and healthy glow reassured them she was truly cared for. That kind of personal, attentive service has been at the heart of this family-run company for over ten years. “We treat every client as our own,” says Maribeth Brigden, case manager. “For us, home care is more than just a service; it’s about family taking care of family.” This deeply personal approach is reflected in Southern California Caregiving’s expertise in dementia care, post-surgery recovery, and support for clients with ALS and multiple sclerosis. The team helps with daily personal care, meal preparation, medication reminders, grooming, and incontinence care—ensuring each client stays clean, well-fed, and on track with their health needs. But the care doesn’t stop there. The company leverages technology to make homes safer and caregiving smarter. Fall detection, medication monitoring, and early infection alerts help prevent emergencies before they happen. Clients enjoy peace of mind knowing their health is being watched over, not just with compassion, but with precision. Southern California adds an additional layer of care and convenience by combining safety services and smart technology. It ensures a comfortable and secure living environment through health monitoring, safety supervision and respite care, all supported by cutting-edge fall detection and health monitoring technology. This thoughtful intake process helps pair each client with the right caregiver, creating a seamless transition and a stronger bond from the start. This system also monitors medication adherence and picks up early signs of infection, allowing caregivers to intervene before a situation becomes critical. Team SoCal Caregiving integrates safety measures with personal care to minimize medication mishaps, prevent avoidable hospital visits and ensure continuous care at home.

Mission and Approach Neuravention Inc. is dedicated to developing advanced therapies for neurovascular diseases, with a specific focus on creating safer, more efficient, and longer-lasting interventions for intracranial aneurysms. Its multidisciplinary teams, comprised of experts in research, engineering, and manufacturing, collaborate closely with clinicians to address real-world procedural challenges encountered in daily practice. Innovative Collaboration and Technology By combining adaptive design engineering with a deep understanding of clinical needs, Neuravention is driving meaningful advancements in the capabilities of current endovascular devices. This approach enables interventionalists to manage complex neurovascular cases with greater confidence and improved patient outcomes. Neuravention is a privately held medical device company based in Buffalo, Minnesota. It was founded in 2020 following years of design and research dating back to 2012, culminating in the introduction of the world’s first next-generation 4D conformable neuro coil system for intracranial aneurysm therapy across all aneurysm geometries. Market Opportunity and Industry Dynamics The global neurovascular intervention market is at a critical inflection point. The commoditization of first-generation endovascular technologies is converging with increasing demand for improved clinical outcomes and procedural efficiency. The global aneurysm coil market is currently valued at approximately USD 2.48 billion in 2025 and is projected to reach USD 4.57 billion by 2035, growing at a compound annual growth rate of 6.3 percent. When viewed within the broader neurovascular intervention landscape, including the rapid expansion of ischemic stroke thrombectomy, the total market opportunity increases significantly. Some forecasts project a compound annual growth rate of 10.0 percent through 2032, reaching nearly USD 8 billion. Neuravention Inc. enters this market not simply as another participant in the embolization coil space, but as a potential disruptor of the prevailing coil compaction paradigm. Through its proprietary CROWN G1 4D™ Embolic Coil System and the Barracuda™ Rapid Detachment System, the company addresses two of the most persistent unmet needs in aneurysm therapy: the high rate of long-term recurrence caused by inadequate packing density, and the procedural inefficiencies associated with legacy detachment mechanisms.